ProJect Pharmaceutics introduces Predictive Formulation Analytics for a rational design of optimized biopharmaceutical formulations.
Munich/Martinsried, December, 2011 Protein drug formulation is particularly challenging due to structural complexity and instability. The biological activity of most recombinant proteins emanates specifically from their 3-dimensional structure which needs to remain unaltered throughout the shelf-life of the product. However, cleavage or aggregation incidents may not only reduce efficacy but also produce adverse immunologic effects. […]
Transforming proteins into pioneering drugs – ProJect Pharmaceutics started operations
New pharmaceutical service provider ProJect Pharmaceutics recently opened facility in Munich/Martinsried Munich, December 13, 2010 – ProJect Pharmaceutics started business operations and opened its laboratory facilities in the Biotech-cluster in Martinsried, near Munich. ProJect Pharmaceutics (PJP) transforms proteins, peptides and delicate small molecules into pioneering drugs. Adding value to client’s bio-therapeutic products is PJP’s mission, […]